HOME >> BIOLOGY >> NEWS
Cannabinoids spell relief in colon inflammation

Max Planck researchers and collaborators from the University in Munich identify the body's own cannabinoid receptor as a protective system against colon inflammation

The development of chronic inflammatory diseases of the gastrointestinal tract such as Crohn's disease and Colitis ulcerosa has not been understood yet, but medication to treat and alleviate these diseases are in high demand. In the current issue of The Journal of Clinical Investigation (15 April 2004) a researcher team from the Max Planck Institute of Psychiatry and from the Ludwig-Maximilans-University Munich were able to show that mutant mice lacking the cannabinoid receptor are much more prone to experimentally induced colon inflammation as compared to wild-type control mice. Moreover, colon muscle activities become uncontrolled after inflammation in these mutant mice. The treatment with cannabinoids was able to alleviate inflammation in wild-type animals. Thus, these results suggest that the endogenous cannabinoid system represents a promising therapeutic target for the treatment of chronic inflammatory diseases of the gastrointestinal tract.

An important defense mechanism of the body after insults is the induction of an inflammation. However, if this response is too strong a destruction of the tissue may occur. Therefore, a balance between pro- and anti-inflammatory responses is very important for the body. Chronic inflammatory diseases of the gastrointestinal tract such as Crohn's disease and Colitis ulcerosa constitute a widespread problem in industrialized countries. These diseases are difficult to be treated successfully and the search for novel therapeutic approaches is of high demand.

During centuries, extracts from Cannabis sativa have been used in folk medicine for the treatment of various gastrointestinal diseases. The most active compound of Cannabis sativa is delta-9-tetrahydrocannabinol, also called THC. The human body contains a receptor for THC and THC-like mo
'"/>

Contact: PD Dr. Beat Lutz
lutz@mpipsykl.mpg.de
49-89-30-622-640
Max-Planck-Gesellschaft
7-May-2004


Page: 1 2 3

Related biology news :

1. UCR geneticist spells out consequences of genetically engineered genes escaping into wild species
2. ORNL instrument could spell doom for Asian beetles
3. Flexible pain relief with morphine-free poppy
4. Puffer fish biotoxin provides promising relief in cancer pain
5. Homegrown relief for victims of arsenic poisoning in South Asia
6. Naked mole-rats bare pain relief clues
7. New therapies under development promise improved relief for Non-Hodgkins Lymphoma cancer patients
8. ENBREL provided rapid and significant relief for psoriasis patients in second pivotal study
9. ENBREL combo therapy inhibits joint damage progression, offers significant RA symptom relief
10. Birth control pill may provide relief for PMS
11. Pain-relief drug may prevent lung problems, blindness in premature infants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... 2020 , ... Nine middle school teachers from eight states ... unique professional development program that provides advanced STEM (science, technology, engineering and math) ... , Created in partnership between the National Stem Cell Foundation and The Gatton ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead upcoming ... term focus on Type 2 diabetes and associated comorbidities. , Justin brings over ... and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues ... An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, ... the most effective way to complete one? Will the study comply with all ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading platform for ... Board (SAB) to research the medical potential of terpenes and the potential entourage ... terpenes. The board is focused on expanding the recently launched line of effects-based terpenes ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine ... global leader in FDA compliance consulting has been named on its annual Inc. ... list represents a unique look at the most successful companies within the American ...
(Date:7/31/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... July 29, 2020 , ... ... cell joint injections for only $3950. With 50 million stem cells total, patients may ... well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
Breaking Biology Technology:
Cached News: